ArQule Message Board - Msg: 5412859

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule

ARQL 20.00

0.0%

Jan 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ahhaha who wrote (281)	8/5/1998 12:58:00 AM
From: Rio Jangada	Read Replies (1) of 399

You raised many excellent points ahhaha! But, I disagree with you regarding ARQL. The company has a price to book value of an amazingly low 1.82, according to Yahoo!. It has many good partners with a vested interest in validating their technology. It is likely that ARQL has the ability and means to adapt their technology and their business to meet the needs of the pharmaceutical business, which happens to be financially better off now then ever and is much less vulnerable to a stock market collapse than other industries. The recent management mishap presents a great opportunity to buy in! As for the evils of pharmaceuticals: in most instances you can deny yourself treatment with them. Natural selection may sort this one out! RJ, by luck I had traded in my ARQL for CRGN 2 weeks ago, but I will soon load up on more.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next